This is strange. . . .will this be grand-fathered into the current FDA approval application of Pfizer or added as a separate EUA? Third shots (which will be kill-shots for the elderly and immuno-compromised) don't have enough safety/efficacy data for the current application, which is supposed to be coming out very soon.
This is strange. . . .will this be grand-fathered into the current FDA approval application of Pfizer or added as a separate EUA? Third shots (which will be kill-shots for the elderly and immuno-compromised) don't have enough safety/efficacy data for the current application, which is supposed to be coming out very soon.